We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NREF
2676
NexPoint Real Estate Finance
NREF
$318M
$78K ﹤0.01%
+4,693
New +$62.2K
PFBC icon
2677
Preferred Bank
PFBC
$1.28B
$78K ﹤0.01%
1,826
+1,066
+140% +$39.2K
VHI icon
2678
Valhi
VHI
$466M
$78K ﹤0.01%
+7,436
New +$79.3K
ZION icon
2679
Zions Bancorporation
ZION
$10.5B
$78K ﹤0.01%
2,291
-5,713
-71% -$181K
AXNX
2680
DELISTED
Axonics, Inc. Common Stock
AXNX
$78K ﹤0.01%
+2,227
New +$76.7K
TTCF
2681
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$78K ﹤0.01%
+4,762
New +$58.4K
MIC
2682
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$78K ﹤0.01%
+2,551
New +$70.6K
ESXB
2683
DELISTED
Community Bankers Trust Corporation
ESXB
$78K ﹤0.01%
14,197
+8,525
+150% +$44.5K
ANIK icon
2684
Anika Therapeutics
ANIK
$283M
$77K ﹤0.01%
+2,040
New +$67.2K
CENX icon
2685
Century Aluminum
CENX
$4.59B
$77K ﹤0.01%
10,788
-2,289
-18% -$12.1K
DXC icon
2686
DXC Technology
DXC
$1.79B
$77K ﹤0.01%
4,649
-11,159
-71% -$177K
EARN
2687
Ellington Residential Mortgage REIT
EARN
$167M
$77K ﹤0.01%
+7,550
New +$67.8K
HSII
2688
DELISTED
Heidrick & Struggles
HSII
$77K ﹤0.01%
+3,560
New +$78.4K
MRNA icon
2689
Moderna
MRNA
$25.4B
$77K ﹤0.01%
+1,193
New +$65.3K
PAHC icon
2690
Phibro Animal Health
PAHC
$1.38B
$77K ﹤0.01%
+2,927
New +$72.7K
REPL icon
2691
Replimune Group
REPL
$1.42B
$77K ﹤0.01%
3,088
+1,597
+107% +$28.2K
ROAD icon
2692
Construction Partners
ROAD
$6.73B
$77K ﹤0.01%
+4,331
New +$73.8K
TUP
2693
DELISTED
Tupperware Brands Corporation
TUP
$77K ﹤0.01%
16,312
+7,679
+89% +$25.6K
NGM
2694
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$77K ﹤0.01%
3,914
+2,590
+196% +$49.5K
EBSB
2695
DELISTED
Meridian Bancorp, Inc.
EBSB
$77K ﹤0.01%
+6,611
New +$73.4K
USCR
2696
DELISTED
U S Concrete, Inc.
USCR
$77K ﹤0.01%
+3,124
New +$62.6K
ATEX icon
2697
Anterix
ATEX
$1.79B
$76K ﹤0.01%
+1,685
New +$86.1K
DFIN icon
2698
Donnelley Financial Solutions
DFIN
$1.22B
$76K ﹤0.01%
+9,048
New +$65.1K
ELS icon
2699
Equity Lifestyle Properties
ELS
$12.6B
$76K ﹤0.01%
1,214
+140
+13% +$8.6K
GEF.B icon
2700
Greif Class B
GEF.B
$4.22B
$76K ﹤0.01%
+1,810
New +$70.9K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.